Precision Antibody

Discusses when and why preclinical programs should consider engineered antibodies for optimal results.

Describes how functional assays can predict clinical trial outcomes and boost regulatory confidence.

Explains the importance of screening and characterization in ensuring efficacy and accelerating drug success.

Highlights the growing importance of rigorous antibody characterization in biomedical research.

Compares fully human and humanized antibodies for safety, efficacy, and speed in drug development.

Guides researchers in selecting the appropriate assay for antibody validation and research.

Outlines key qualities to look for in a contract research organization for antibody drug discovery.

Explores antibody engineering, including humanization, ADCs, bispecifics, and strategies for therapeutic use.

Details the benefits of fully human monoclonal antibodies in drug development, including safety and efficacy.

Describes Precision Antibody's approach to rapid and effective custom antibody development for drug discovery.

Explains the role of custom polyclonal antibodies in research and diagnostics.

Discusses the importance of biochemical and molecular characterization in antibody development.

Explores the benefits of early antibody humanization for drug safety, cost, and development speed.

Describes how humanized antibodies enhance safety and success in therapeutic applications.

Explains the significance of functional assays in validating antibody-based drugs.

Comprehensive guide on the stages and benefits of custom antibody development for therapeutics.

Discusses the impact of custom anti-idiotype antibodies on precision, safety, and efficiency in drug development.

Highlights the advantages of fully human monoclonal antibodies in therapeutic development.

Overview of the importance and process of custom antibody development in medicine and research.

Compares traditional cancer treatments with monoclonal antibody therapies.

Describes the use of trans-chromosomic mice and proprietary technology to develop fully human antibodies rapidly.

Precision Antibody's contribution to the development of novel antibody reagents for the RAS signaling network as part of the National Cancer Institute’s RAS initiative.

An overview of fully human monoclonal antibody development, highlighting their effectiveness in complex disease treatment and the process from concept to clinical application.

Explores six key benefits of custom antibody development for targeting difficult antigens, enhancing research, diagnostics, and therapeutic advancements.

Discusses the importance of antibody purification for achieving consistent results in biotechnology applications.

Explains how custom polyclonal antibodies, with their ability to recognize multiple epitopes, are essential for advanced therapeutic discovery.

Describes the impact of fully human monoclonal antibodies on cancer therapy, offering targeted and effective treatment options.

Provides a checklist for biotech teams to select the right antibody purification partner for quality and compliance.

Highlights the foundational role of mammalian cell banking in producing high-quality antibodies for biopharmaceuticals.

Provides tips and strategies for maintaining antibody stability during long-term storage to prevent degradation.

Discusses why mammalian cell banking is essential for antibody development, ensuring consistency and risk protection.

Identifies common mistakes in outsourcing antibody development and how to avoid them for faster therapeutic success.

Dr. Ginette Serrero, CEO of A&G Pharmaceutical Inc., DBA Precision Antibody, presented two posters at the American Association of Cancer Research’s annual meeting.